Financial Statements — SOLV
Balance Sheet
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.40 | 0.56 | 1.64 | 0.49 | 0.53 | 0.77 | 0.90 | 1.00 |
| Accounts Receivable | 1.31 | 1.06 | 1.02 | 1.07 | 0.93 | 1.11 | 1.03 | 1.22 |
| Inventory | 1.04 | 1.09 | 1.05 | 0.96 | 0.87 | 0.95 | 0.90 | 0.90 |
| Total Current Assets | 3.74 | 3.58 | 4.41 | 3.21 | 3.05 | 3.35 | 3.36 | 3.36 |
| Property, Plant & Equipment | 1.57 | 1.54 | 1.34 | 1.31 | 1.20 | 1.60 | 1.54 | 1.49 |
| Goodwill | 5.63 | 5.63 | 5.26 | 5.27 | 4.99 | 6.59 | 6.45 | 6.47 |
| Intangible Assets | 2.41 | 2.50 | 2.22 | 2.30 | 2.37 | 2.65 | 2.72 | 2.79 |
| Total Non-current Assets* | 10.50 | 10.51 | 9.57 | 11.87 | 11.47 | 11.39 | 11.22 | 11.35 |
| Total Assets | 14.24 | 14.10 | 13.97 | 15.07 | 14.53 | 14.75 | 14.58 | 14.71 |
| Accounts Payable | 0.70 | 0.70 | 0.67 | 0.64 | 0.60 | 0.56 | 0.50 | 0.59 |
| Short-term Debt | 0.51 | 0.51 | 0.00 | 0.00 | 0.10 | 0.30 | -- | -- |
| Total Current Liabilities | 3.66 | 3.35 | 2.94 | 2.62 | 2.57 | 2.90 | 2.57 | 1.85 |
| Long-term Debt | 4.57 | 4.58 | 5.14 | 7.82 | 7.91 | 8.11 | 8.31 | 8.30 |
| Total Non-current Liabilities* | 5.78 | 5.78 | 6.05 | 8.81 | 8.70 | 8.65 | 9.14 | 9.01 |
| Total Liabilities | 9.44 | 9.13 | 8.99 | 11.43 | 11.27 | 11.55 | 11.71 | 10.86 |
| Retained Earnings | 1.90 | 1.81 | 1.73 | 0.47 | 0.38 | 0.21 | 0.09 | -- |
| Total Stockholder Equity | 4.80 | 4.97 | 4.99 | 3.65 | 3.26 | 3.19 | 2.87 | 3.85 |
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.21 | 2.01 | 2.00 | 2.10 | 2.16 | 2.07 | 2.08 | 2.08 | 2.08 | 2.02 |
| Cost of Revenue* | 0.92 | 0.91 | 0.97 | 0.96 | 0.99 | 0.96 | 0.96 | 0.92 | 0.94 | 0.84 |
| Gross Profit | 1.29 | 1.10 | 1.03 | 1.14 | 1.18 | 1.11 | 1.12 | 1.17 | 1.14 | 1.17 |
| Research & Development | 0.18 | 0.19 | 0.17 | 0.18 | 0.19 | 0.19 | 0.20 | 0.19 | 0.19 | 0.20 |
| Selling, General & Admin | 0.93 | 0.83 | 0.76 | 0.78 | 0.77 | 0.77 | 0.78 | 0.70 | 0.70 | 0.60 |
| Total Operating Expenses | 1.11 | 1.02 | 0.90 | (0.56) | 0.96 | 0.96 | 0.98 | 0.89 | 0.89 | 0.77 |
| Operating Income | 0.18 | 0.08 | 0.13 | 1.69 | 0.21 | 0.15 | 0.14 | 0.28 | 0.24 | 0.38 |
| Pretax Income | 0.11 | 0.02 | 0.06 | 1.51 | 0.10 | 0.04 | 0.01 | 0.17 | 0.10 | 0.33 |
| Tax Provision | 0.02 | 0.00 | -0.00 | 0.25 | 0.01 | (0.10) | (0.02) | 0.05 | 0.01 | 0.09 |
| Net Income | 0.09 | 0.01 | 0.06 | 1.27 | 0.09 | 0.14 | 0.03 | 0.12 | 0.09 | 0.24 |
| Basic EPS | 0.53 | 0.07 | 0.37 | 7.26 | 0.52 | 0.79 | 0.19 | 0.70 | 0.51 | 1.37 |
| Diluted EPS | 0.53 | 0.07 | 0.37 | 7.22 | 0.51 | 0.78 | 0.18 | 0.70 | 0.51 | 1.37 |
* Derived from reported values
Cash Flow Statement
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 0.23 | (0.19) | 0.10 | 0.08 | 0.17 | 0.03 | 0.22 | 0.17 | 0.36 | 0.44 |
| Capital Expenditures | 0.08 | 0.08 | 0.06 | 0.10 | 0.11 | 0.11 | 0.13 | 0.09 | 0.06 | 0.10 |
| Free Cash Flow* | 0.14 | (0.27) | 0.03 | (0.02) | 0.06 | (0.08) | 0.09 | 0.08 | 0.30 | 0.34 |
| Investing Cash Flow | (0.09) | (0.08) | (0.74) | 3.77 | (0.11) | (0.11) | (0.13) | (0.09) | (0.06) | (0.10) |
| Financing Cash Flow | (0.30) | (0.05) | (0.11) | (2.69) | (0.11) | (0.14) | (0.10) | (0.20) | (0.40) | 0.46 |
* Derived from reported values